Here, we for the first time reported a function of miR‐194 in nasopharyngeal carcinoma and established an association between miR‐194 and MAP3K3, which is in line with the inhibitory role of miR‐194 in cancer regression. This evidence concerns the gene MAP3K3 and nasopharyngeal carcinoma.